XML 39 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Options
A summary of the status of the stock options under the 2014 Plan as of December 31, 2022, and changes during the year then ended is presented below:
Number of OptionsWeighted- Average Exercise PriceWeighted-Average Remaining Contractual Term (In Years)Aggregate Intrinsic Value
Balance - December 31, 20218,371,097 $0.29 7.3325,773 
Granted— — 
Exercised(295,203)0.23 
Forfeited/Expired(4,510)0.85 
Balance - December 31, 20228,071,384 $0.30 6.325,479 
Exercisable - December 31, 20228,063,747 $0.29 6.325,479 
Unvested - December 31, 20227,637 $3.50 7.79— 
A summary of the status of the stock options under the 2021 Plan as of December 31, 2022, and changes during the year then ended is presented below:
Number of OptionsWeighted- Average Exercise PriceWeighted-Average Remaining Contractual Term (In Years)Aggregate Intrinsic Value
Balance - December 31, 2021346,603 $10.45 9.50$— 
Granted— — 
Exercised— — 
Forfeited— — 
Balance - December 31, 2022346,603 $10.45 8.50$— 
Exercisable - December 31, 2022180,522 10.45 8.50$— 
Unvested - December 31, 2022166,081 $10.45 8.50$— 
Summary of Stock Options Valuation Assumptions The weighted-average assumptions used to estimate the fair value of stock options granted during the years ended December 31, 2022 and 2021 are as follows:
Years Ended December 31,
20222021
Exercise price$— $10.45 
Risk-free interest rate— %1.02 %
Expected term (in years)— 5.78
Expected volatility— %66.90 %
Expected dividend yield0 %0 %
Summary of RSUs
A summary of the status of RSU's under the 2021 Plan as of December 31, 2022, and changes during the year then ended is presented below:
Number of RSUsWeighted Average Grant Date Fair Value
Outstanding - December 31, 20212,115,162 $6.10 
Granted 5,957,968 1.78 
Vested(946,091)5.96 
Forfeited(985,925)3.30 
Outstanding - December 31, 20226,141,114 $2.38